Albert S Yu Selected Research

Albert S Yu Research Topics

2	Heart Failure 10/2022 - 09/2019
2	Sepsis (Septicemia) 01/2022 - 06/2021
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2015 - 05/2014
1	Atherosclerosis 04/2022
1	Ischemic Stroke 01/2022
1	Infections 01/2022
1	COVID-19 01/2022
1	Cardiac Arrhythmias (Arrythmia) 09/2019
1	Fibrosis (Cirrhosis) 09/2019
1	Heart Diseases (Heart Disease) 09/2019
1	Hypertrophy 09/2019
1	Metabolic Diseases (Metabolic Disease) 01/2016
1	Lymphoid Leukemia 12/2015
1	Inflammation (Inflammations) 02/2015
1	Lymphadenopathy 05/2014
1	Anemia 05/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2014
1	Neutropenia 05/2014
1	Thrombocytopenia (Thrombopenia) 05/2014
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 05/2005
1	Pain (Aches) 05/2005

3	idelalisibIBA 12/2015 - 05/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2021
2	LipidsIBA 02/2015 - 05/2014
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2022
1	Neprilysin (Neutral Endopeptidase)IBA 10/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022
1	Angiotensin Receptor AntagonistsIBA 10/2022
1	Apolipoproteins E (ApoE)IBA 04/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Extracellular Matrix ProteinsIBA 09/2019
1	Rituximab (Mabthera)FDA Link 12/2015
1	Ion Channels (Ion Channel)IBA 02/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2014
1	Transaminases (Aminotransferases)IBA 05/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2014
1	Phosphotransferases (Kinase)IBA 05/2014
1	TRPV Cation ChannelsIBA 05/2005
1	resiniferatoxinIBA 05/2005